Multiple Myeloma CancerConnect
Overview of Multiple Myeloma
Symptoms, diagnosis and overview of Multiple Myeloma
Understanding Stem Cell Transplants for Multiple Myeloma
2019 ASH update: ASCT treatment of multiple myeloma improves outcomes even in individuals older than 70.;
Treatment for Stage II - III Multiple Myeloma
Treatment of stage II-III myeloma may include chemotherapy, precision medicines, stem cell transplant & supportive care.
Multiple Myeloma Cancer Connect is a unique resource that brings patients, caregivers, advocates and experts together in a single community where individuals benefit from a blend of expert-authored news and educational programming alongside a robust social network, providing insight into symptoms, diagnosis, treatment, and the support of other individuals being treated at some of the best cancer centers. Multiple Myeloma Cancer Connect offers users expert authored clinically-reviewed information and the perspective of their peers in a safe, objective space, helping to ensure they become empowered in their healthcare journey.
Multiple Myeloma Cancer Connect is a unique resource that brings patients, caregivers, advocates and experts together in a single community where individuals benefit from a blend of expert-authored news and educational programming alongside a robust social network, providing insight into symptoms, diagnosis, treatment, and the support of other individuals being treated at some of the best cancer centers. Multiple Myeloma Cancer Connect offers users expert authored clinically-reviewed information and the perspective of their peers in a safe, objective space, helping to ensure they become empowered in their healthcare journey.
Multiple Myeloma Overviews
Supportive Care for Multiple Myeloma
Management of bone complications, anemia, infections and other complications of Multiple Myeloma
Treatment of Recurrent Multiple Myeloma
Cancer Connect - Treatment of Recurrent Multiple Myeloma
Treatment of Stage I & "Smoldering" Multiple Myeloma
Monoclonal gammopathy of undetermined significance (MGUS), smoldering multiple myeloma, and stage I multiple myeloma.
Managing Complications & Side Effects of Myeloma
Managing Complications & Side Effects of Myeloma
Multiple Myeloma Treatment
REGN5458 Bispecific Antibody in Multiple Myeloma
Bispecific Antibodies appear promising for treatment of advanced myeloma-2022 Annual Myeloma Meeting Update.
Talquetamab fo Multiple Myeloma
Talquetamab is a CPRC5DxCD3 Bispecific Antibody being developed for the treatment of myeloma - ASH 2021 Update.
CAR-T Cell Therapy - Advances in The Management of Multiple Myeloma
FDA Approves 2nd CAR T-cell therapy for multiple myeloma, ASCO 2022 update.
COVID-19 Vaccines and Cancer - Evushield "Authorized"
Preventing COVID-19 in Cancer. Answers to frequently asked questions about vaccination and Evushield.
Multiple Myeloma Survivorship
Blood Cancers and COVID-19 - What You Need to Know
COCID-19 puts individuals with leukemia, lymphoma, myeloma and MPN's at risk - learn how to optimize your care.
COVID-19 Vaccination in Patients with Blood Cancers
Studies of COVID-19 vaccine effectiveness in myeloma and lymphoma available - vaccine relatively ineffective.
Advances offer Promise for Multiple Myeloma Patients
Dr. Bill Benisnger M.D. of Swedish Cancer Inst. discusses the growing number of treatment options for Multiple Myeloma